| Tag | Content |
|---|
EnhancerAtlas ID | HS113-21909 |
Organism | Homo sapiens |
Tissue/cell | Keratinocyte |
Coordinate | chr20:1445340-1447360 |
Target genes | | Number: 11 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF16 | MA0741.1 | chr20:1447061-1447072 | GCCACGCCCCC | + | 6.62 | | SP1 | MA0079.4 | chr20:1447058-1447073 | GCAGCCACGCCCCCA | + | 6.11 | | SP3 | MA0746.2 | chr20:1447060-1447073 | AGCCACGCCCCCA | + | 6.34 | | SP8 | MA0747.1 | chr20:1447061-1447073 | GCCACGCCCCCA | + | 6.11 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09488 | chr20:1443267-1463477 | CD14 | | SE_13234 | chr20:1446177-1449344 | CD34_Primary_RO01480 | | SE_13889 | chr20:1445610-1449872 | CD34_Primary_RO01536 | | SE_33872 | chr20:1446276-1447575 | HCC1954 | | SE_36032 | chr20:1445625-1447662 | HMEC |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CTAGTAAAAG TAGCACACAT TTAGTGAGCA TTTACATGCC AGGTTGTTCT GAGCATTCTA 60
CATACGTTAA TTTGTTTAAT CCTCAAGAAC TCTATGCTAT TAGTACTCTT ATCATCTCAT 120
TTTATAGTTG ATACAGAAGC ACTGAGGATT AAAAAAAAAT TTGTTCAAGT TTACACAACT 180
GGTAAAGAGA GGAGCCAGGT TCCATCCCTG CTAGTGTGCT TAGGCCCTCA CTCTTAAGCG 240
CTTCCAGTAC AGCCCGGAGT CAGGAACTGT GGAGTCAGTC CAGGTTGCTA CTTTTCCTTT 300
CTTTCAAGTT GTTTCCTAAT CTGTGAAATG GGGGTACCTG TCTCACCAAC CTGCACACTG 360
GATGAGATAA TCCATTAAGA TTTATGCATA CTCGCATCTT AGGTTTACAC ATACAGAAGG 420
AATATGGGAA TCCTTTGGTC ATTTGTGACA TCTCTGTCAC CAACTCAACG GACAGGCATT 480
CACTAATCAC TTGCTTTGCA CAAACACAAG AAAGCATTGA GGTCACAGAG ATGAAATAGA 540
CATGGCCTCT GTCCTCAGGG TCACCAACTT CACAGGAGAC AGTGAGCTGT CAAGGGATAA 600
AAGTAATCTG CTGGGAGGCA GTGTGCTGTC TCAGGCCATG TAGTGAACTG GCATTCTCAG 660
GGAGCCTACA TTCAAGTCCT GTTCCTGCCA GGCAAGTCAC ATGCATGATC CTCAGTTTCC 720
CCACTACAAT GTGAGGGGAA CGAGACAGAA GATCTGTTGG TCACAACACT GTGTGCTTTT 780
AGGTCTTTCA GGTAGAAACT TTTTATTTCT GCCCAGCATA GGGGCTTCCC ATTGTGTCTA 840
GGTGTGATCT AGGTGTGATG CTTTACCGAA TTCTTATGTT TGGGGAGTAA TTTACGTTTG 900
GCAGCAGACT CAGTTCAAAT TCCAACCCCG CTACTTACTG GCTATGTGAC CCTGAGCAAA 960
TTCTTTGCCC TCTGTGCTTC CAATTCCTCA TCCATAAAAT GGGTCTAGTC TTTACCTCAT 1020
AGTGTTGCTA GGATCCAACG AATCATATTA TGTAAAGTGC TTGGCACATG GTGGTTTAAA 1080
GCTTGGGCTC TGTCTGCTTG CAATCAGACA GAACTGGGTT CCACTTCTAC CTCTTCTGCC 1140
TGGTAGCTAG TGAGGCCTTG AGCAAGTTAC TTAACCTCTT TAATCTCAGC TGCAAAATGC 1200
GAAGGTTAAA TGACAAAAGA CATGTAAAGC AGTCAGAACA GCGCTTGGCT CATGGTAGGT 1260
ACTCAATAAA TATTAGTCAT CACCGTCATC ATCTACCTAA GACGAAGCTG GCCAAGAATA 1320
TTTATGCAAT TCTTTCTACA GTTAATTACC GAATGCTTAT TATGTGCCAG GCATTGTTCC 1380
AGGCACTGGG AATTCATCAG TGTACAAAAA TCCCTGCCTC GTGAAGCTTA AGTCTTCTTA 1440
GCAAGTATTT AGTGAATACT CAGTACGTGC CAATGAACTA CACAGCAATT TCCACGAGAC 1500
TCCCATTTTA CAGATAAGTT AACTACGCAA GGTGAAGAAG CTCCAACCTT GCGCCACCAC 1560
CCCAGAGGTA TTCTCCCAGC AATTAGGAAG GCTGGGCGGC GGTCAACTCC CGGGCTGGAC 1620
TTCGGAAGTG GAAATGAGCG GCCACCTAGT CCCGAGTGGG GCTTCACCCA AGAGCTGCTC 1680
ACTCGGACCA GCCCGGCCTC CAGCAGATAC TCGGCGCGGC AGCCACGCCC CCAGGCGCTC 1740
CCTCTCCTCG CCGGCTGCCG CAGCGCCCGA AGTCTCGCTG ACGCCGCAAG CGGGCGAGGC 1800
AGGGTGAAAC TGGCACGGCA GAACTGGCTG GGGCTGGCCC GCGTTCCCCC ACTCCCAAGC 1860
CGAGCAGGCG ACGCGTGACA AGCGGTCCCG GGACCATGAG GCCTGGGTCG GGCCGCGGTA 1920
GAGCGGGGAT GACTGTGCGC TTCGGCCGCC GCGGGCTTAA GGCACCAGGC GCCCGCTCCC 1980
AGCAGTCCCC GGCCCACCCG ACACAGCCCG CCGCGCGGCG 2020
|
